## Background: It is not yet known whether screening for the detection of early prostate carcinoma will reduce mortality rates. however, data are available to assess intermediate outcomes from screening, including the performance characteristics of the screening tests and shifts in disease stage.
The detection of prostatic carcinoma
โ Scribed by R. Vleeming; J. W. Noordzij; Th. M. Reijke; K. H. Kurth
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 664 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
โฆ Synopsis
In this prospective study a comparison of 4versus 7-MHz transrectal ultrasonography for the detection of prostatic carcinoma is reported. A total of 150 prostates were biopsied due to suspicion of malignancy arising at either digital rectal examination, 4-and/or 7-MHz transrectal ultrasonography, or elevated serum prostate-specific antigen levels. Malignancies of the prostate were detected in 68 of the 147 eligible biopsy core specimens. The results show only marginal differences in the sensitivity, specificity, and predictive values for the two transducers.
(PSA), and 4-and 7-MHz TRUS in the same session. All patients were referred because of suspected carcinoma at rectal examination, due to elevated PSA values, or for determination of the volume of a tactile benign prostatic enlargement (Table 1). Patients with fixed tumor or tumor invading adjacent structures (T4 tumors) were not considered in this study. Transrectal ultrasonography was performed using Bruel & Kjaer equipment (type 1846) in combination with a 4-MHz transaxial scanner (type 1850; focus, 30-70 mm) or a 7-MHz multiplane scanner (type 8551, focus 10-60mm). In all patients, ultrasonographically guided core specimens were obtained by the transrectal route from echopenic areas and from suspected areas on DRE. In patients showing an elevated PSA level without suspicion on DRE or TRUS, one to two random biopsies of the prostate were taken bilaterally.
๐ SIMILAR VOLUMES
## BACKGROUND. Prostate specific antigen (PSA) is the most useful marker for prostate carcinoma (Cap). However, the sensitivity and specificity for PSA are not sufficient for the diagnosis of organ-confined prostate carcinoma. Recent studies have revealed that anti-PSA antibody identifies both PSA
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr
Transrectal ultrasonography (TRUS) has become the most frequently used imaging modality for the prostate. The internal architecture of the prostate is readily detailed by TRUS, and the procedure allows an accurate measurement of prostate size. Carcinoma of the prostate has a characteristic hypoechoi
This case report describes the unanticipated results of a transrectal ultrasound performed to stage a cancer of the rectum. During sonography, the normally dense prostate peripheral zone produced weak echoes indicating the existence of an unexpected carcinoma of the prostate. The presence of extensi